2003/0151(CNS)

Research RTD, 6th framework programme 2002-2006: funding for projects on stem cells (amend. Decision 2002/834/EC)

Procedure lapsed or withdrawn

2003/0151(CNS) Research RTD, 6th framework programme 2002-2006: funding for projects on stem cells (amend. Decision 2002/834/EC)
RoleCommitteeRapporteurShadows
Opinion ENVI BLOKLAND Johannes (EDD)
Lead ITRE LIESE Peter (PPE-DE)
Opinion JURI GARGANI Giuseppe (PPE-DE)
Lead committee dossier: ITRE/5/19939
Legal Basis EC Treaty (after Amsterdam) EC 166-p4
Subjects
Links

Activites

  • 2008/03/13 Proposal withdrawn by Commission
  • 2007/06/25 Resolution/conclusions adopted by Council
  • #2811
  • 2007/06/25 Council Meeting
  • #2550
  • 2003/12/03 Council Meeting
  • #2547
  • 2003/11/26 Council Meeting
  • 2003/11/26 Modified legislative proposal
    • COM(2003)0749 summary
    • DG Research and Innovation, POTOČNIK Janez
  • 2003/11/19 Text adopted by Parliament, 1st reading/single reading
    • T5-0506/2003 summary
    • OJ C 087 07.04.2004, p. 0076-0390 E
  • 2003/11/17 Debate in Parliament
  • 2003/11/04 Committee report tabled for plenary, 1st reading/single reading
  • 2003/10/29 Economic and Social Committee: opinion, report
  • 2003/10/01 Committee draft report
    • PE322.041
  • 2003/09/01 Committee referral announced in Parliament, 1st reading/single reading
  • 2003/07/09 Legislative proposal
    • COM(2003)0390 summary
    • DG Research and Innovation, POTOČNIK Janez

Documents

History

(these mark the time of scraping, not the official date of the change)

2012-02-09
activities added
  • date
    2003-07-09
    docs
    • url
      http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2003&nu_doc=0390
      text
      • PURPOSE : to amend decision 2002/834/EC on the specific programme for research, technological development and demonstration : "Integrating and Strengthening the European Research Area" (2002-2006).
        CONTENT : to recall, the 6th Research Framework Programme (FP6 2003-2006), as adopted by the Council of Ministers and the European Parliament in 2002, allows for the funding of human embryonic stem cell research in relation to the fight against major diseases. Such research, in particular when it involves the derivation of stem cells from human supernumerary embryos, can only take place within a framework of clear and strict ethical guidelines. The EU research programme includes ethical provisions related to sensitive areas of research. In light of the sensitive nature of human embryonic stem cell research, the Council and the Commission agreed at the time of the decision-making process on FP6 that further ethical guidelines would be adopted before the end of 2003 for deciding on and for monitoring the EU funding of human embryonic stem cell research.
        The Commission now submits, based on Article 166, paragraph 4, of the Treaty, a proposal to the Council for the modification of the specific programme, on which the European Parliament will express its opinion.
        This proposal presents a coherent set of strict ethical guidelines that will apply to the EU funding of research projects involving the derivation of stem cells from human supernumerary embryos.
        In order to be funded by the Community, research projects involving the procurement of stem cells from human embryos must also meet the following conditions:
        - prior to the start of research activities, participants must obtain ethical advice at local or national level in the countries where the research will be carried out;
        - the human embryos used for the procurement of stem cells must have been created before 27 June 2002 as a result of medically-assisted in vitro fertilisation designed to induce pregnancy, and were no longer to be used for that purpose;
        - the project must serve particularly important research aims to advance scientific knowledge in basic research or to increase medical knowledge for the development of diagnostic, preventive or therapeutic methods to be applied to humans;
        - all other alternative methods (including existing or adult stem cell lines) must have been examined and demonstrated not to be sufficient for the purposes of the research in question;
        - the free, express, written and informed consent of the donor(s) should be provided in accordance with national legislation prior to the start of the research activities;
        - no monetary compensation or other benefit in kind must be granted or promised for the donation;
        - the protection of personal data, including the genetic data, of the donor(s) must be ensured;
        - where appropriate, the participants in research projects must follow quality and safety standards on donation, procurement and storage in accordance to the state of the art, in order to ensure in particular the traceability of these stem cells.
        The scientific evaluation and the ethical review organised by the Commission of the research proposals shall include verification of these conditions. The conditions shall be assessed during thescientific evaluation.
        The opinions of the European Group on Ethics in Science and New Technologies, and in particular those relating to research involving the use of human embryonic stem cells will be taken into account.
        The participants in research projects should use their best efforts to make the newly derived human embryonic stem cell lines available to the scientific community on a non-profit making basis for research purposes.
        A list of research projects involving the use of all types of human embryonic stem cells funded under the sixth framework programme will be published yearly by the Commission.
      celexid
      CELEX:52003PC0390:EN
      type
      Legislative proposal published
      title
      COM(2003)0390
    body
    EC
    commission
    • DG
      Research and Innovation
      Commissioner
      POTOČNIK Janez
    type
    Legislative proposal
  • date
    2003-09-01
    body
    EP
    type
    Committee referral announced in Parliament, 1st reading/single reading
    committees
  • date
    2003-10-01
    docs
    • type
      Committee draft report
      title
      PE322.041
    body
    EP
    type
    Committee draft report
  • date
    2003-10-29
    docs
    body
    ESOC
    type
    Economic and Social Committee: opinion, report
  • body
    EP
    committees
    docs
    • url
      http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A5-2003-0369&language=EN
      type
      Committee report tabled for plenary, 1st reading/single reading
      title
      A5-0369/2003
    text
    • The committee adopted the report by Peter LIESE (EPP-ED, D) amending the proposal under the consultation procedure as follows:
      - whereas the Commission was proposing that human embryos used for the procurement of stem cells must have been created before 27 June 2002 (the date of adoption of the 6th framework programme), the committee said that the embryos must be 'supernumerary' early-stage (i.e. up to 14 days) but did not specify a cut-off date for their creation;
      - any decision on whether or not to allow funding of research on the use of human stem cells should depend both on the contents of the scientific proposal and the legal framework of the Member States involved;
      - support should also be given to research projects using adult somatic stem cells and umbilical cord blood cells;
      - research using adult stem cells and reprogrammed adult cells should get priority for financing;
      - research on embryo or foetal stem cells deriving from spontaneous or therapeutic abortion may be funded;
      - the prior agreement of the parents must be secured in cases where embryos are to be destroyed in order to produce human embryonic stem cell lines;
      - the Commission should set up a European register of embryonic stem cells, using the experience of the NIH (a leading US public medical research centre);
      - the list of research projects funded under the 6th framework programme involving the use of human embryonic stem cells, which is to be published yearly by the Commission, must include a justification stating why other procedures were not usable.
    date
    2003-11-04
    type
    Committee report tabled for plenary, 1st reading/single reading
  • date
    2003-11-17
    body
    EP
    type
    Debate in Parliament
  • date
    2003-11-19
    docs
    body
    EP
    type
    Text adopted by Parliament, 1st reading/single reading
  • date
    2003-11-26
    body
    CSL
    type
    Council Meeting
    council
    Competitiveness (Internal Market, Industry, Research and Space)
    meeting_id
    2547
  • date
    2003-11-26
    docs
    • url
      http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2003&nu_doc=0749
      text
      • In general, the amendments adopted by Parliament tally with the approach proposed by the Commission by allowing the Community funding of research projects involving the procurement of human embryonic stem cells from supernumerary embryos and hence the creation of new lines.
        However, certain amendments, and in particular those aimed at removing the cut-off date for the creation of supernumerary embryos call into question the approach adopted by the Commission on 9 July 2003.
      celexid
      CELEX:52003PC0749:EN
      type
      Modified legislative proposal published
      title
      COM(2003)0749
    body
    EC
    commission
    • DG
      Research and Innovation
      Commissioner
      POTOČNIK Janez
    type
    Modified legislative proposal
  • body
    CSL
    meeting_id
    2550
    text
    • The Council examined a text put forward by the Presidency, following the Council's deliberations at its meeting on 26 November, on the establishment of implementing provisions for Community funding of research projects involving the use of human embryos and human embryonic stem cells.
      At the end of the discussion, the President concluded that no agreement could be reached either on the Commission's amended proposal or on the Presidency text. The Commission, for its part, could not support the Presidency text.
    council
    Competitiveness (Internal Market, Industry, Research and Space)
    date
    2003-12-03
    type
    Council Meeting
  • date
    2007-06-25
    text
    • The Council adopted conclusions on the coordination of Community funding programmes for research. It acknowledged the importance of improving synergies and complementarity between large Community funding programmes, including in the area of research and innovation policy as well as regional policy, in light of their respective goals.

      It recognised the substantial work done by CREST in analysing the possibilities to better coordinate the use of the Research Framework Programme and the Structural Funds to support R&D and welcomed the guidelines document and the 14 recommendations adopted at the 314th CREST meeting on 7 May 2007.

      The Council recalled the six priority domains identified in the CREST guidelines:

      • Develop RTDI strategies and strengthen the governance,
      • Strengthen and develop the RTDI basis,
      • Develop RTDI excellence,
      • Develop R&D cooperation at European and international level,
      • Strengthen exploitation and economic and social valorisation of R&D results,
      • Improve communication and information.

      The importance of improved communication between actors involved in FP and SF activities, was emphasised.

      The Member States were called upon to implement the guidelines at national and regional level on a voluntary basis. It encouraged policy-makers to disseminate them widely in their area of responsibility.

      The Council welcomed the Commission's intention to bring forward a Communication on Competitive European Regions Through Research and Innovation. It supported the idea that the impetus created by the adoption of FP 7 should be used and that the subject merits further discussion and follow-up activities at a European, national and regional scale, for example through qualified bodies such as CREST, COCOF, EURAB, involving the Committee of the Regions and regional policy and research and innovation experts.

      Lastly, it underlined the particular importance of further discussion and follow-up activities on the development of RDTI strategies and the strengthening of governance and the development of RDTI excellence in this context.

    body
    type
    Resolution/conclusions adopted by Council
  • date
    2007-06-25
    body
    CSL
    type
    Council Meeting
    council
    Competitiveness (Internal Market, Industry, Research and Space)
    meeting_id
    2811
  • date
    2008-03-13
    body
    type
    Proposal withdrawn by Commission
    text
    • As announced in Official Journal C 68 of 13 March 2008, the Commission decided to withdraw this proposal, which had become obsolete.
committees added
  • body
    EP
    responsible
    False
    committee
    ENVI
    date
    2003-09-09
    committee_full
    Environment, Public Health, Consumer Policy
    rapporteur
    • group
      EDD
      name
      BLOKLAND Johannes
  • body
    EP
    responsible
    True
    committee
    ITRE
    date
    2003-07-10
    committee_full
    Industry, External Trade, Research, Energy
    rapporteur
    • group
      PPE-DE
      name
      LIESE Peter
  • body
    EP
    responsible
    False
    committee
    JURI
    date
    2003-10-20
    committee_full
    Legal Affairs and Internal Market
    rapporteur
    • group
      PPE-DE
      name
      GARGANI Giuseppe
links added
other added
  • body
    EC
    dg
    Research and Innovation
    commissioner
    POTOČNIK Janez
procedure added
dossier_of_the_committee
ITRE/5/19939
reference
2003/0151(CNS)
subtype
Legislation
legal_basis
  • EC Treaty (after Amsterdam) EC 166-p4
stage_reached
Procedure lapsed or withdrawn
instrument
Decision
title
Research RTD, 6th framework programme 2002-2006: funding for projects on stem cells (amend. Decision 2002/834/EC)
type
CNS - Consultation procedure
subject

code AGPLv3.0+, data ODBLv1.0, site-content CC-By-Sa-3.0
© European Union, 2011 – Source: European Parliament